Skip to content

Y-Intercept (Hong Kong) Ltd

Follow

13F filer, CIK 1772875, HONG KONG, Hong Kong

Y-Intercept (Hong Kong) Ltd reported $4,089,672,594 across 1,587 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-01. Its ten largest share positions make up 6.33% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001772875-25-000024

Period
2025-06-30
Reported value
$4.09B
Holdings
1,587
Top 10 weight
6.33%
New
963
Sold out
518

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NUnew+2,319,643$31.8M
UNHadded+98,932$30.9M
TMUSadded+124,456$29.7M
RKLBnew+778,510$27.8M
INTCadded+1,134,895$25.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ANETexited-218,796-$17M
NVOreduced-237,147-$16.4M
MRVLexited-263,328-$16.2M
NOWexited-16,679-$13.3M
WMTreduced-113,095-$11.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Back to all 1,587 share positions

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
LFTLUMENT FINANCE TRUST INC29,563$77.2Kshares
SVRASAVARA INC26,661$73.9Kshares
ALLOALLOGENE THERAPEUTICS INC43,940$64.2Kshares
IKTINHIBIKASE THERAPEUTICS INC26,775$58.6Kshares
IRWDIRONWOOD PHARMACEUTICALS INC39,782$58.5Kshares
BRBSBLUE RIDGE BANKSHARES INC VA17,595$57.4Kshares
DMACDIAMEDICA THERAPEUTICS INC13,335$50.5Kshares
SGMOQSANGAMO THERAPEUTICS INC72,077$47.3Kshares
AIRJAIRJOULE TECHNOLOGIES CORP10,038$46.3Kshares
OLMAOLEMA PHARMACEUTICALS INC10,882$40.9Kshares
ELDNELEDON PHARMACEUTICALS INC12,065$40.9Kshares
FDMT4D MOLECULAR THERAPEUTICS IN12,627$40.8Kshares
Rithm Property Trust IncRithm Property Trust Inc14,200$40.8Kshares
ATYRATYR PHARMA INC12,583$38Kshares
GEVOGEVO INC30,940$35.9Kshares
HIVEHIVE DIGITAL TECHNOLOGIES LT21,632$31.4Kshares
TUYATUYA INC10,168$30.8Kshares
AIIOROBO.AI INC.36,936$11.7Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001772875-25-000024 base2025-08-01acceptance time not in the bulk data set